<DOC>
	<DOC>NCT00803361</DOC>
	<brief_summary>This is a 15 week study comparing how well duloxetine and placebo treatments improve generalized anxiety disorder</brief_summary>
	<brief_title>Duloxetine for the Treatment of Generalized Anxiety Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Psychiatric Diagnosis of generalized anxiety disorder (GAD) Outpatients Meet Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSMIV) diagnosis for GAD Clinical Global Impression (CGI) of Severity Score of at least moderate Sheehan Disability Scale (SDS) Global Functioning Impairment Score &gt;= 12 Pregnancy or breast feeding Serious medical illness Other primary psychiatric diagnoses, such as major depressive disorder or substance abuse disorder within the past 6 months panic disorder, posttraumatic stress disorder (PTSD), or eating disorder in the last year lifetime history of bipolar or psychosis Any unstable serious medical condition for which duloxetine would not be allowed Any use of medications that are not allowed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>anxiety</keyword>
</DOC>